Eleven Biotherapeutics Stock Analysis
Technical stock analysis for 31 May 2018
|Shorts||0.78% ( 2018-04-30 )|
No changes to the price of Eleven Biotherapeutics in the last trading day. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
Close price at the end of the last trading day (Thursday, 31st May 2018) of the EBIO stock was $3.29.
During day the stock fluctuated 0.00% from a day low at $3.29 to a day high of $3.29.
30 day high of the EBIO stock price was $3.50 and low was $2.52.
90 day high was $3.50 and low was $0.90.
52 week high for the Eleven Biotherapeutics - $3.50 and low - $0.62.
Eleven Biotherapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 216.77% during the next 3 months and, with 90% probability hold a price between $9.18 and $13.24 at the end of this period.
Eleven Biotherapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.29 and $2.67. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday May 30, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
The stock holds a RSI14 at 84 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
Eleven Biotherapeutics finds support from accumulated volume at $3.22.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 0.00%.
Our recommended stoploss: $3.18 (-3.32%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 84 and this increases the risk substantially. There is a sell signal from pivot top found 1 days ago.)
Very Low Low Medium High Very High
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.